Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia substudy of an intima-media thickness trial

Circulation

Volumn 112, Issue 20, 2005, Pages 3168-3173

  Koeijvoets, Kristel C M C ^a   Rodenburg, Jessica ^b   Hutten, Barbara A ^b   Wiegman, Albert ^b   Kastelein, John J P ^b   Sijbrands, Eric J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Carotid arteries; Drugs; Genetics; Hypercholesterolemia, familial; Pediatrics

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; PRAVASTATIN;

ADOLESCENT; ADULT; ALLELE; ANALYSIS OF COVARIANCE; ARTICLE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; SCHOOL CHILD;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CORONARY VESSELS; DOUBLE-BLIND METHOD; FEMALE; GENE DELETION; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; PLACEBOS; PRAVASTATIN; RECEPTORS, LDL; TUNICA INTIMA; TUNICA MEDIA;

EID: 30944467711     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.565507     Document Type: Article

References (21)

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307.
3. Sijbrands EJG, Lombardi MP, Westendorp RGJ, Gevers Leuven JA, Meinders AE, van der Laarse A, Frants RR, Havekes LM, Smelt AHM. Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations. Atherosclerosis. 1998;136:247-254.
4. Gaw A, Tolmie E, Lindsay GM. The statin breakthrough: remembering to involve the patient. Cardiovasc Drugs Ther. 2004;18:343-344.
5. Jeenah M, September W, Graadt van Roggen F, de Villiers W, Seftel H, Marais D. Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia. Atherosclerosis. 1993;98:51-58.
6. Leitersdorf E, Eisenberg S, Eliav O, Friedlander Y, Berkman N, Dann EJ, Landsberger D, Sehayek E, Meiner V, Wurm M, Bard J-M, Fruchart J-C, Stein Y. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia. Circulation. 1993;87(suppl III):III-35-III-44.
7. Vuorio AF, Ojala J-P, Sama S, Turtola H, Tikkanen MJ, Kontula K. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment. J Intern Med. 1995;237:43-48.
8. Sun X-M, Patel DD, Knight BL, Soutar AK, for the Familial Hypercholesterolaemia Regression Study Group. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. Atherosclerosis. 1998;136:175-185.
9. Kajinami K, Yagi K, Higashikata T, Inazu A, Koizumi J, Mabuchi H. Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia. Am J Cardiol. 1998;82:113-117.
10. Chaves FJ, Real JT, García- García AB, Civera M, Armengod ME, Ascaso JF, Carmena R. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. J Clin Endocrinol Metab. 2001;86:4926-4932.
11. Vohl M-C, Szots F, Lelièvre M, Lupien P-J, Bergeron J, Gagné C, Couture P. Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia. Atherosclerosis. 2002;160:361-368.
12. Koeijvoets KCMC, Wiegman A, Rodenburg J, Defesche JC, Kastelein JJP, Sijbrands EJG. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study. Atherosclerosis. 2005;180:93-99.
13. De Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart J-C, Kastelein JJP. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109(suppl III):III-33-III-38.
14. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Scharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146:483-494.
15. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262-269.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
17. Wiegman A, de Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, Sijbrands EJG, Kastelein JJP. Arterial intima-media thickness in children heterozygous for familial hypercholesterolemia. Lancet. 2004;363:369-370.
18. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJG, Kastelein JJP. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;229:331-337.
19. Friedewald WT, Levy F, Frederickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without the use of preparative ultra centrifugation. Clin Chem. 1972;18:499-509.
20. Fouchier SW, Defesche JC, Umans-Eckenhausen MAW, Kastelein JJP. The molecular basis of familial hypercholesterolemia in the Netherlands. Hum Genet. 2001;109:602-615.
21. Schultz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365:1348-1353.